Farther Finance Advisors’s Alterity Therapeutics ATHE Stock Holding History

Farther Finance Advisors’s Portfolio ATHE Stock Details ATHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$858	Buy	236 +197	+505%	+$893	﹤0.01%	5626
2026 Q2	$205	Buy	39 +17	+77%	+$74	﹤0.01%	5715
2026 Q1	$80	Hold	22	–	–	﹤0.01%	5535
2025 Q4	$68	Hold	22	–	–	﹤0.01%	5329
2025 Q3	$83	Buy	+22	New	+$106	﹤0.01%	4835

Other funds holding ATHE

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Farther Finance Advisors's ATHE Position: Q3 2026 in Review

Farther Finance Advisors increased its Alterity Therapeutics (ATHE) stake by 505% in Q3 2026, buying an estimated $893 and bringing the position to 236 shares worth $858. The position accounts for ﹤0.01% of the portfolio, ranked #5626.

Farther Finance Advisors first reported a position in ATHE in Q3 2025 and has held it in 5 quarters since. 3 funds tracked by Wall St. Rank hold ATHE as of Q3 2026.

Farther Finance Advisors held 236 shares of Alterity Therapeutics worth $858 as of Q3 2026.
Farther Finance Advisors bought 197 Alterity Therapeutics shares in Q3 2026, an estimated $893.
Alterity Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5626 holding.
Farther Finance Advisors first reported a position in Alterity Therapeutics in Q3 2025 and has held it in 5 quarters since.
3 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.